tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
PVLA
Palvella Therapeutics
RESEARCH TOOLSreports
Want to see PVLA full AI Analyst Report?

Palvella Therapeutics (PVLA) Income Statement

779 Followers

Palvella Therapeutics Income Statement

Last quarter (Q4 2025), Palvella Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Palvella Therapeutics's net income was $-12.71M. See Palvella Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 25.90M$ 31.42M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 23.12M$ 29.05M
Operating Expenses
$ 38.60M$ 14.10M$ 11.87M$ 66.60M$ 80.88M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 2.78M$ 2.37M
EBITDA
$ -35.90M$ -13.12M$ 18.69M$ -30.50M$ -43.37M
Operating Income
$ -38.60M$ -14.10M$ -11.87M$ -43.47M$ -51.83M
Other Income/Expenses
$ -3.11M$ -3.34M$ 30.56M$ 10.20M$ 6.09M
Pretax Income
$ -41.72M$ -17.43M$ 18.69M$ -33.28M$ -45.74M
Net Income
$ -41.72M$ -17.43M$ 18.69M$ -33.28M$ -45.74M
Per Share Metrics
Basic EPS
$ -3.71$ -7.83$ 14.74$ -29.61$ -56.69
Diluted EPS
$ -3.71$ -7.83$ 14.74$ -29.61$ -56.69
Weighted Average Shares Outstanding
 11.25M 2.23M 1.27M 930.35K 806.84K
Weighted Average Shares Outstanding (Diluted)
 11.25M 2.23M 1.27M 930.35K 806.84K
Currency in USD

Palvella Therapeutics Earnings and Revenue History